Comparison of molecular determinants of angiogenesis and lymphangiogenesis in lymph node metastases and in primary tumours of patients with breast cancer.
The Evolution and Prognostic Role of Tumour-Infiltrating Lymphocytes and Peripheral Blood-Based Biomarkers in Inflammatory Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
Autorzy:
Van Berckelaer C; Translational Cancer Research Unit, GZA Hospitals, 2000 Antwerp, Belgium.; Multidisciplinary Breast Clinic, Unit Gynaecologic Oncology, Antwerp University Hospital (UZA), 2650 Edegem, Belgium.; Center of Oncological Research (CORE), MIPRO, IPPON, University of Antwerp, 2610 Wilrijk, Belgium. Vermeiren I; Multidisciplinary Breast Clinic, Unit Gynaecologic Oncology, Antwerp University Hospital (UZA), 2650 Edegem, Belgium. Vercauteren L; Multidisciplinary Breast Clinic, Unit Gynaecologic Oncology, Antwerp University Hospital (UZA), 2650 Edegem, Belgium. Rypens C; Translational Cancer Research Unit, GZA Hospitals, 2000 Antwerp, Belgium.; Center of Oncological Research (CORE), MIPRO, IPPON, University of Antwerp, 2610 Wilrijk, Belgium. Oner G; Multidisciplinary Breast Clinic, Unit Gynaecologic Oncology, Antwerp University Hospital (UZA), 2650 Edegem, Belgium.; Department of General Surgery, Kocaeli University, Kocaeli 410040, Turkey. TrinhXB; Multidisciplinary Breast Clinic, Unit Gynaecologic Oncology, Antwerp University Hospital (UZA), 2650 Edegem, Belgium.; Center of Oncological Research (CORE), MIPRO, IPPON, University of Antwerp, 2610 Wilrijk, Belgium. Tjalma WAA; Multidisciplinary Breast Clinic, Unit Gynaecologic Oncology, Antwerp University Hospital (UZA), 2650 Edegem, Belgium.; Center of Oncological Research (CORE), MIPRO, IPPON, University of Antwerp, 2610 Wilrijk, Belgium. Broeckx G; Center of Oncological Research (CORE), MIPRO, IPPON, University of Antwerp, 2610 Wilrijk, Belgium.; Department of Pathology, UZA, Antwerp University Hospital, 2650 Edegem, Belgium. Charafe-Jauffret E; Predictive Oncology Team, Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM, CNRS, Institut Paoli-Calmettes, Aix-Marseille Université, 13273 Marseille, France. Van Laere S; Center of Oncological Research (CORE), MIPRO, IPPON, University of Antwerp, 2610 Wilrijk, Belgium. Bertucci F; Predictive Oncology Team, Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM, CNRS, Institut Paoli-Calmettes, Aix-Marseille Université, 13273 Marseille, France. Colpaert C; Center of Oncological Research (CORE), MIPRO, IPPON, University of Antwerp, 2610 Wilrijk, Belgium. van Dam PA; Multidisciplinary Breast Clinic, Unit Gynaecologic Oncology, Antwerp University Hospital (UZA), 2650 Edegem, Belgium.; Center of Oncological Research (CORE), MIPRO, IPPON, University of Antwerp, 2610 Wilrijk, Belgium.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Sep 16; Vol. 13 (18). Date of Electronic Publication: 2021 Sep 16.
Acceptability of quality indicators for the management of endometrial, cervical and ovarian cancer: results of an online survey.
Autorzy:
Luyckx A; Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Wilrijkstraat 10, B2650, Edegem, Belgium. Wyckmans L; Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Wilrijkstraat 10, B2650, Edegem, Belgium. Bonte AS; Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Wilrijkstraat 10, B2650, Edegem, Belgium. TrinhXB; Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Wilrijkstraat 10, B2650, Edegem, Belgium.; Centre for Oncological Research (CORE), University of Antwerp, B2610, Wilrijk, Belgium. van Dam PA; Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Wilrijkstraat 10, B2650, Edegem, Belgium. .; Centre for Oncological Research (CORE), University of Antwerp, B2610, Wilrijk, Belgium. .
Pokaż więcej
Źródło:
BMC women's health [BMC Womens Health] 2020 Jul 23; Vol. 20 (1), pp. 151. Date of Electronic Publication: 2020 Jul 23.
RANK-RANKL Signaling in Cancer of the Uterine Cervix: A Review.
Autorzy:
van Dam PA; Multidisciplinary Oncologic Center Antwerp (MOCA), Antwerp University Hospital, B2650 Edegem, Belgium. .; Center for Oncological Research (CORE), University of Antwerp, B2610 Wilrijk, Belgium. . Verhoeven Y; Multidisciplinary Oncologic Center Antwerp (MOCA), Antwerp University Hospital, B2650 Edegem, Belgium. .; Center for Oncological Research (CORE), University of Antwerp, B2610 Wilrijk, Belgium. . Jacobs J; Center for Oncological Research (CORE), University of Antwerp, B2610 Wilrijk, Belgium. . Wouters A; Center for Oncological Research (CORE), University of Antwerp, B2610 Wilrijk, Belgium. . Tjalma W; Multidisciplinary Oncologic Center Antwerp (MOCA), Antwerp University Hospital, B2650 Edegem, Belgium. .; Center for Oncological Research (CORE), University of Antwerp, B2610 Wilrijk, Belgium. . Lardon F; Center for Oncological Research (CORE), University of Antwerp, B2610 Wilrijk, Belgium. . Van den Wyngaert T; Center for Oncological Research (CORE), University of Antwerp, B2610 Wilrijk, Belgium. .; Department of Nuclear Medicine, Antwerp University Hospital, B2650 Edegem, Belgium. . Dewulf J; Center for Oncological Research (CORE), University of Antwerp, B2610 Wilrijk, Belgium. .; Department of Nuclear Medicine, Antwerp University Hospital, B2650 Edegem, Belgium. . Smits E; Center for Oncological Research (CORE), University of Antwerp, B2610 Wilrijk, Belgium. . Colpaert C; Multidisciplinary Oncologic Center Antwerp (MOCA), Antwerp University Hospital, B2650 Edegem, Belgium. .; Department of Histopathology, Antwerp University Hospital, B2650 Edegem, Belgium. .; Department of Histopathology, Gasthuiszusters Antwerpen (GZA) Hospitals, B2610 Wilrijk, Belgium. . Prenen H; Multidisciplinary Oncologic Center Antwerp (MOCA), Antwerp University Hospital, B2650 Edegem, Belgium. .; Center for Oncological Research (CORE), University of Antwerp, B2610 Wilrijk, Belgium. . Peeters M; Multidisciplinary Oncologic Center Antwerp (MOCA), Antwerp University Hospital, B2650 Edegem, Belgium. .; Center for Oncological Research (CORE), University of Antwerp, B2610 Wilrijk, Belgium. . Lammens M; Multidisciplinary Oncologic Center Antwerp (MOCA), Antwerp University Hospital, B2650 Edegem, Belgium. .; Department of Histopathology, Antwerp University Hospital, B2650 Edegem, Belgium. . TrinhXB; Multidisciplinary Oncologic Center Antwerp (MOCA), Antwerp University Hospital, B2650 Edegem, Belgium. XuanBich.Trinh@uza.be.; Center for Oncological Research (CORE), University of Antwerp, B2610 Wilrijk, Belgium. XuanBich.Trinh@uza.be.
A dynamic clinical pathway for the treatment of patients with early breast cancer is a tool for better cancer care: implementation and prospective analysis between 2002-2010.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
